ALK rearrangements, particularly its fusion with echinodermal microtubule-associated protein-like 4, are common in NSCLC, with ALK mutations present in approximately 5% of cases, mostly patients with LUAD (71–74). Here, ALK is linked to non-small cell lung carcinoma.